{
    "clinical_study": {
        "@rank": "1627", 
        "acronym": "STABLE I", 
        "arm_group": {
            "arm_group_label": "Endovascular", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The Zenith\u00ae Dissection Clinical Trial is a clinical trial approved by US FDA to study the\n      safety and effectiveness of the Zenith\u00ae Dissection Endovascular System in the treatment of\n      patients with aortic dissection."
        }, 
        "brief_title": "Zenith\u00ae Dissection Endovascular System", 
        "completion_date": {
            "#text": "February 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Aortic Dissection", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Branch vessel obstruction/compromise\n\n          -  Peri-aortic effusion/hematoma\n\n          -  Resistant hypertension\n\n          -  Persistent pain/symptoms\n\n          -  Transaortic growth >5 mm within 3 months\n\n          -  Transaortic diameter >40 mm.\n\n        Exclusion Criteria:\n\n          -  Age <18 years;\n\n          -  Other medical condition (e.g., cancer, congestive heart failure) that may cause the\n             patient to be non-compliant with the protocol, confound the results, or is associated\n             with limited life expectancy (i.e., less than 2 years)\n\n          -  Pregnant, breast-feeding, or planning on becoming pregnant within 24 months;\n\n          -  Unwilling or unable to comply with the follow-up schedule\n\n          -  Inability or refusal to give informed consent\n\n          -  Simultaneously participating in another investigative device or drug study.  (The\n             patient must have completed the primary endpoint of any previous study at least 30\n             days prior to enrollment in this study.)\n\n          -  Additional medical restrictions as specified in the Clinical Investigation Plan, or\n\n          -  Additional anatomical restrictions as specified in the Clinical Investigation Plan."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02094300", 
            "org_study_id": "05-622"
        }, 
        "intervention": {
            "arm_group_label": "Endovascular", 
            "description": "Instead of making a large incision in the chest, the physician makes a small incision near each hip to insert, and guide the study device(s) into place in the aorta.", 
            "intervention_name": "Zenith\u00ae Dissection Endovascular Graft", 
            "intervention_type": "Device", 
            "other_name": [
                "Endovascular graft", 
                "Stent-graft"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Aorta", 
            "Thoracic", 
            "Aortic dissection", 
            "Rupture", 
            "Type B", 
            "DeBakey type III", 
            "Endovascular"
        ], 
        "lastchanged_date": "March 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Gainesville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32610"
                    }, 
                    "name": "University of Florida"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston,", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetss General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Camden", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "08103"
                    }, 
                    "name": "Cooper University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195"
                    }, 
                    "name": "Cleveland Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadephia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19107"
                    }, 
                    "name": "Thomas Jefferson University Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Zenith\u00ae Dissection Endovascular System", 
        "overall_official": {
            "affiliation": "Cooper University Hospital", 
            "last_name": "Joseph Lombardi, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Percentage of patients with major adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02094300"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Cook", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cook", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2007", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}